1. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer
    Fang-Tao Wang et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
  2. Galectin-9: An anticancer molecule for gallbladder carcinoma
    TOMOKO TADOKORO et al, 2016, International Journal of Oncology CrossRef
  3. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
    Michael J. Viereckl et al, 2022, Biomolecules CrossRef
  4. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma
    Jisce R Puik et al, 2017, Pharmacogenomics CrossRef
  5. Encapsulated microRNA by gemcitabine prodrug for cancer treatment
    Hai-Tao Zhang et al, 2019, Journal of Controlled Release CrossRef
  6. Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study
    Tomoko Tadokoro et al, 2017, International Journal of Oncology CrossRef
  7. Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein
    Xiansheng Lin et al, 2016, Oncotarget CrossRef
  8. Plasma checkpoint protein 1 (Chk1) as a potential diagnostic biomarker for opisthorchiasis and cholangiocarcinoma
    Teva Phanaksri et al, 2022, Cancer Biomarkers CrossRef
  9. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
    Tomas Koltai et al, 2022, Cancers CrossRef
  10. Combined chemotherapy based on bioactive black phosphorus for pancreatic cancer therapy
    Shengyong Geng et al, 2023, Journal of Controlled Release CrossRef
  11. Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers
    Dan Høgdall et al, 2020, Clinical Cancer Research CrossRef
  12. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
    Belén Toledo et al, 2024, Expert Review of Clinical Pharmacology CrossRef
  13. Differentially expressed proteins in the human esophageal cancer cell line Eca‑109, in the presence and absence of gemcitabine
    Zenghuang Ma et al, 2017, Molecular Medicine Reports CrossRef
  14. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma
    Fei Feng et al, 2017, Cancer Biology & Therapy CrossRef
  15. Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
    Annamaria Massa et al, 2022, Frontiers in Oncology CrossRef
  16. Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma
    Dan Høgdall et al, 2018, Trends in Cancer CrossRef
  17. High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver Cancer
    Ievgen V. Pylypchuk et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef